RWS
GMAB icon

Retirement Wealth Solutions’s Genmab GMAB Stock Holding History

Retirement Wealth Solutions’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$880 Buy
32
+29
+967% +$771 ﹤0.01% 672
2026
Q1 		$81 Sell
3
-11
-79% -$330 ﹤0.01% 802
2025
Q4 		$432 Buy
+14
New +$436 ﹤0.01% 693

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Retirement Wealth Solutions's GMAB Position: Q2 2026 in Review

Retirement Wealth Solutions increased its Genmab (GMAB) stake by 967% in Q2 2026, buying an estimated $771 and bringing the position to 32 shares worth $880. The position accounts for ﹤0.01% of the portfolio, ranked #672.

Retirement Wealth Solutions first reported a position in GMAB in Q4 2025 and has held it in 3 quarters since. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Retirement Wealth Solutions held 32 shares of Genmab worth $880 as of Q2 2026.
  • Retirement Wealth Solutions bought 29 Genmab shares in Q2 2026, an estimated $771.
  • Genmab made up ﹤0.01% of Retirement Wealth Solutions's portfolio in Q2 2026, its #672 holding.
  • Retirement Wealth Solutions first reported a position in Genmab in Q4 2025 and has held it in 3 quarters since.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Retirement Wealth Solutions's 13F filing for Q2 2026, filed 7 Jul 2026.